Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.07.2023 | Case report

Elasomeran

Guillain Barre syndrome and idiopathic thrombocytopenic purpura: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Lazaro C, et al. Guillain-Barre syndrome and thrombocytopenia after SARS-CoV-2 vaccination with Moderna. A case report. [Spanish]. Revista de Neurologia 75 : 247-250, No. 8, 2022. Available from: URL: http://doi.org/10.33588/RN.7508.2022138 [Spanish; summarised from a translation] Lazaro C, et al. Guillain-Barre syndrome and thrombocytopenia after SARS-CoV-2 vaccination with Moderna. A case report. [Spanish]. Revista de Neurologia 75 : 247-250, No. 8, 2022. Available from: URL: http://​doi.​org/​10.​33588/​RN.​7508.​2022138 [Spanish; summarised from a translation]
Metadaten
Titel
Elasomeran
Guillain Barre syndrome and idiopathic thrombocytopenic purpura: case report
Publikationsdatum
01.07.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-42288-4

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Nitrofurantoin

Case report

Metformin

Case report

Flecainide

Case report

Salbutamol